LIVE EVENT
GCN Investor Conference in Newport Beach, CA
OCT 15 · NEWPORT BEACH, CA
LIVE EVENT
.png)
Pricing your startup’s first round is one of the most misunderstood — and emotionally charged — decisions a founder makes.
Go too high, and you scare away savvy investors.
Go too low, and you give away too much ownership too early.
Here’s how to value your startup at the pre-seed or seed stage, even before you have major revenue or traction.
At early stages, valuation isn’t just a math equation — it’s a mix of:
VCs and angels aren’t pricing your company — they’re pricing risk.
These are ballparks. Industry, geography, and team all shift the numbers.
YC’s standard SAFE in 2024 was $3M–$5M cap at pre-seed.
Your fundraising instrument affects how “price” is perceived.
💡If unsure, use a SAFE with a cap + discount (e.g., $5M cap, 20% discount)
Even pre-revenue, you can justify value using:
✅ Example:
“We’ve signed 8 LOIs with enterprise customers averaging $12K ACV. That’s $96K in pre-launch demand.”
Look up funding rounds on:
Find:
Create a mini comp set to guide your expectations.
Your valuation should leave room for:
🔢 Example Math:
Don’t just raise the most you can — raise what you can deploy efficiently over 12–18 months.
It’s normal for investors to challenge your price.
Come prepared with:
Be ready to adjust — especially if you’re a first-time founder or lack traction.
Going too low may:
A fair deal respects both sides of the table.
The advice to use a SAFE with a cap and a discount is where most founders stop reading, and it is where the expensive misunderstandings begin. A cap is not a valuation. It is a ceiling on the price at which your SAFE converts later — and since Y Combinator moved its standard instrument to a post-money SAFE in 2018, that ceiling has behaved very differently from the way most founders assume.
Under a pre-money SAFE, an investor's final percentage depended on what else converted alongside them. Under a post-money SAFE, the percentage is fixed the moment it is signed. If someone puts in $750,000 on a $6M post-money cap, they own 12.5% of the company after conversion — $750,000 divided by $6M — and nothing you do afterwards dilutes them out of it. Every subsequent SAFE, every expansion of the option pool, every share issued before the priced round dilutes you, not them.
That distinction compounds, because SAFEs stack. Consider a founder who raises in two tranches:
The arithmetic is simple and unforgiving. $1.25M raised has already sold 18.75% of the company, and the priced round has not happened yet. The Series A investor's 20% comes out of the remaining 81.25%, and so does the option pool. Founders who tracked only the headline caps routinely arrive at their Series A having sold a third of the business without ever having signed a priced term sheet.
Two practical consequences follow. First, track cumulative converted ownership rather than caps. Keep a simple model showing what every outstanding SAFE becomes as a percentage, and update it the day you sign each one — the number that matters is the total, and it is invisible if you only ever look at instruments individually. Second, treat the discount as the secondary term it is. A 20% discount binds only when the priced round comes in below the cap; if your round prices above it, the cap governs and the discount never applies. Founders routinely negotiate hard on the discount and concede on the cap, which is precisely backwards.
Section 6 recommends leaving room for a 10–15% option pool. What it does not say — and what founders tend to discover at signing — is that the pool is almost always created before the new money goes in, which means the founders fund all of it.
A worked example. You agree to raise $2M at an $8M pre-money valuation, so the company is worth $10M post-money and the investor takes 20%. The term sheet then specifies a 12% post-close option pool, created pre-money. That pool is 12% of the $10M post-money company — $1.2M of value — and it is carved out of your $8M, not out of the combined total.
The valuation you actually agreed to is 15% lower than the number on the term sheet, and nobody has misled you. This is the standard structure, and an investor will describe it accurately if asked. The problem is that founders compare offers on headline pre-money while the pools attached to those offers differ by five or six points, which can easily outweigh the headline difference.
The negotiable element is not whether the pool exists but how large it is. Investors propose a pool sized to a hiring plan they have never seen; you should arrive with one they have. Build the plan for the 12–18 months the round is meant to fund, price each role's grant against market benchmarks, total it, and propose that figure. A 9% pool defended role by role is far more persuasive than resisting 15% on principle, and the gap between those two numbers is often worth more than anything you will win arguing about valuation. Our guide to the option pool shuffle works through the mechanics in more detail.
Two structural terms deserve the same scrutiny as price, because both can quietly outrank it. Liquidation preferences determine what you take home at exit regardless of the valuation you negotiated, and anti-dilution provisions determine what happens to that position if the next round prices lower. A clean 1x non-participating preference at a modest valuation is very often worth more than a headline number attached to a participating one.
The market tells you whether your price is right well before it tells you with money, and most founders misread the signal because they hear every objection as being about the number. It usually is not. Learning to read the response is the difference between a deliberate repricing and a raise that drifts for six months.
Signs you are priced too high. The clearest is not rejection but a particular kind of enthusiasm: investors who take the second meeting, say genuinely positive things, and then go quiet or ask to be kept warm until the next milestone. A pass that arrives quickly is information about fit. A pass that arrives slowly, after real engagement, is usually information about price. Watch also for conversations that keep returning to the cap rather than to the business — when an investor is arguing about valuation, they have already decided they want in and are negotiating; when they are asking about retention or pipeline, they have not.
Signs you are priced too low. Speed is the tell. If term sheets arrive faster than you expected, if a single investor tries to take the entire round, or if nobody attempts to negotiate the cap at all, you left money on the table. A round that closes without a single price conversation was not efficiently priced — it was cheap, and the people who bought it knew.
The asymmetry between those two errors is what should govern your decision, and it is not symmetrical at all. Overpricing costs you time; underpricing costs you ownership permanently. Time is recoverable if you have runway, which is one more argument for raising with 18–24 months rather than 12. Ownership sold at a low cap is gone, and it is gone at the worst possible moment, because early shares are the ones that dilute through every subsequent round.
That suggests a practical sequence rather than a single decision. Open the raise with a handful of investors you would be pleased to have on the cap table but who are not your first choice, and treat those conversations as calibration. You will learn within five or six meetings whether your number survives contact — whether people engage with it, argue with it, or quietly disengage. Then approach your priority targets with a figure you have already tested, which is a materially stronger position than defending a number you picked from a blog post.
If you do need to move, move deliberately. A cap you lower as an announced decision, with a stated reason — a longer runway requirement, a revised hiring plan, a change in what you are raising for — reads as a founder managing a process. The same reduction conceded in a meeting under pressure reads as distress, and investors compare notes far more than founders expect. Reprice once, explain it, and hold the new number.
One caveat worth stating plainly: a raise that stalls at every price is not a pricing problem. If lowering the cap twice has not produced a term sheet, the market is telling you something about traction, team or timing, and further discounting will not fix it. At that point the useful question is what evidence would change the answer, and whether you have the runway to go and get it.
No, and treating it as the only variable is how founders end up with an impressive cap and a punishing structure. A $12M cap paired with a 2x participating liquidation preference, full-ratchet anti-dilution and a 15% pre-money pool can leave you materially worse off at exit than an $8M cap on clean terms. Price is one term among several, and the ones that decide what you actually receive tend to sit further down the document than the ones founders benchmark against their peers.
Give a range with reasoning attached, rather than either a single figure or a refusal. A flat refusal reads as inexperience, and a precise number offered without support invites the investor to take it apart. A range anchored to a comparable set — same stage, same vertical, raised in the last 12–18 months — moves the conversation onto evidence, which is where a well-prepared founder wants it. It also gives you somewhere to move without appearing to capitulate, because you conceded within a range you had already justified.
Legally no; commercially it is usually worth trying. Different caps within what everyone regards as a single round create a disclosure problem, and many SAFEs carry a most-favoured-nation clause precisely to address it. An investor who later discovers that someone got a better cap will invoke the MFN if they hold one, and will quietly reprice their view of you if they do not. A genuine rolling close with a cap that rises as milestones are hit is defensible, but only if you say so at the outset rather than after the fact.
Enough to reach a milestone that measurably changes your risk profile, plus a buffer for the raise taking longer than planned — for most companies that means 18–24 months of runway rather than the 12 founders tend to model. Raising more at a higher cap feels like winning, and it sets a bar the next round has to clear. If it does not clear, you are negotiating a flat or down round from a weak position. The question is not how much you can raise but how much you can convert into evidence before you have to raise again, and the metrics that evidence is judged against are reasonably well established.
.webp){kind=logo}
.png)
.png)